Stand aside — setup invalidated
Setup score 82, but distribution days reach 5 or more — stand aside until the condition resets.
Simple research view
ELV · Elevance Health, Inc.
$416.54 +4.95% Sep 10 close
Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.
$ELV
Elevance Health, Inc.Elevance Health, Inc. is a large-cap Managed Health Care company in the Health Services sector with a market cap of $90B.
Verdict · setup score 82/100 · data Sep 10 close · 1 session old
Stand aside — setup invalidated
Setup score 82, but distribution days reach 5 or more — stand aside until the condition resets.
Earnings
Normal technical setup
Next earnings
Monday, October 19, 2026
Before market open
Exact clock time not supplied by source
Deterministic evidence
ELV+4.95%
Sector proxy · XLV-0.55%
Broad market · SPY-0.60%
Session internals Mixed
Rule: direction and internals disagree — it met neither the strong nor the weak rule. Judged on internals, not on the size of the move.
Vs prior close+4.95%
From the open+2.25%
Range position66%
GapHeld
QQQ confirmationDiverging (-1.06%)
SMH confirmationDiverging (-2.44%)
Short-term conviction -1 points.
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.
- QQQ, SMH moved against the stock — no index confirmation.
Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.
More stats
52W Low
$274.84
Tight Wks
0
Base
B1
SMA 200
$360.57
RS Line vs High
-4.5%
RS Line Slope
+7.4% ▲
Group Rank
#7/58
ADR%
2.3%
ATR(14)
$10.47 (2.5%)
Vol Pace (live)
N/A
U/D Vol
1.74
A/D Days
14A / 11D
A/D Rating
A
VDU Bars
0/10 d
Power Trend
1d
Earnings
in 37d
ELV Chart
Interactive price, volume, RS, RSI, and MACD charts are available after sign in.
Technical Analysis Report Card
$ELV · $416.54 · as of 2026-09-10 · multi-factor read
92
/ 100
Reference read from price & volume only — the verdict at the top of the page decides the action.
Trend · Daily / Weekly / Monthly
Daily
▲ Uptrend
Weekly
▬ Sideways / consolidating
Monthly
▲ Uptrend
Moving Averages
50-day$397.20 ↑
100-day$391.13 ↑
200-day$360.57 ↑
Bullish (50 > 200)
RSI (14)
Reading60.2 · Bullish
Bullish momentum — comfortably in buyer territory.
MACD (12/26/9)
StateBullish
Histogram+0.830
Bullish — MACD above its signal line and above zero. Histogram expanding.
Bollinger Bands (20,2)
%B / Width110% · 6.5%
Squeeze — volatility compressing
Riding the upper band — strong momentum, but stretched. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.
Volume · Buyer vs Seller
Up/Down vol1.74 · Accumulation
Rel volume1.55×
Accumulation — volume is concentrated on up days; buyers dominate. Recent volume is easing versus its baseline.
Support & Resistance
R · $426.98swing level
R · $436.2452-week high
Price · $416.54now
S · $390.80swing level
S · $382.77swing level
S · $364.18swing level
Fibonacci · Uptrend swing
23.6%$399.95
38.2%$377.50
50.0%$359.35
61.8%$341.20
78.6%$315.37
Retracement support zones measured from the recent swing low up to the high.
The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for ELV — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Daily uptrendMonthly uptrendAbove 200-day MA50/200 bullishVolume accumulation
Want this read in a legend's voice?
Ask a Legend about ELV
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts
6 methodology checks
Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
Council consensus:
1 legend rates this Buyable · 4 watching · 1 avoid.
Watch
Minervini C
Trend-template read: 7/11 pass; wait for the soft misses to improve.
Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $416.54, MA150 $363.91, MA200 $360.57
1.2 150-day MA > 200-day MAMA150 $363.91 vs MA200 $360.57
Failing evidence
1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 64
2. Quarterly EPS growth ≥ 25%From SEPA scan
Avoid
O'Neil D
CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
Passing evidence
N: Near 52-week high or RS line new high4.5% below high | RS line new high: False
S: Volume ≥ 40% above average on breakoutVolume ratio 1.54x
Failing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 64
C: Quarterly EPS acceleration ≥ 25%Data unavailable
Buyable
Weinstein A
Stage-analysis read: Stage 2 with 7/7 measured criteria passing.
Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $416.54 vs MA200 $360.57
Failing evidence
No failing criteria.
Watch
Livermore B
Pivotal-point read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$416.54
Volume vs average1.54x
Failing evidence
Relative strengthRS 64
Pivotal point cleared on expanding volumeNot confirmed
Watch
Darvas B
Box-theory read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$416.54
Volume vs average1.54x
Failing evidence
Relative strengthRS 64
Box top broken on heavy volumeNot confirmed
Watch
Wyckoff B
Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$416.54
Volume vs average1.54x
Failing evidence
Relative strengthRS 64
Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending
Base & Breakout
Breakout follow-through
No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?
RS Line vs SPY
52-week relative strength · blue = RS line · dashed = MA50 · dot = NH
▲ Rising
Accumulation / Distribution
last 65 sessions · green = acc on high vol · red = dist on high vol
Net -3
Fundamentals & leadership quality — Minervini’s published criteria · 2/7 met
C
2/7 criteria
Separate score from the Minervini Trend Template (7/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ
—
Revenue growth ≥20% YoY
+12%
Gross margin ≥30%
—
ROE ≥17%
—
RS rating ≥80 (leadership)
64
Stage 2 uptrend (Weinstein)
Stage 2
Within 25% of 52W high
-4.5%
Method Playbook
Trade it like Livermore
EXACT LEVELS · PRO
Livermore B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro levelPublished-method rule: Treat the resistance break as a pivotal point only while the primary trend and relative strength remain aligned.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro levelPublished-method rule: Wait for price and volume to confirm the pivotal-point break; anticipation below the line is not confirmation.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro levelPublished-method rule: Place the initial stop below the pivotal line or the reaction low that would prove the breakout false.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-basedPublished-method rule: Raise protection beneath successive higher reaction lows as the trend advances; never move a protective line farther away.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro levelPublished-method rule: Exit when price fails the pivotal line, breaks the latest meaningful reaction low, or shows abnormal reversal action.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →
Forming Patterns (predictive — not confirmed)
Head & Shoulders
bearish
forming
75%
built
Possible head & shoulders top — not confirmed. Watch for a daily close below ~338.37 (neckline) to confirm, with measured-move risk toward ~240.50. A push back above 410.29 weakens the pattern; reclaiming 436.24 invalidates it.
Confirms below
338.37
Invalidates at
436.24
Left Shoulder
426.98
Head
436.24
Right Shoulder
410.29
Neckline
338.37
Target
240.50
LS 426.98 / head 436.24 / RS 410.29, neckline ~338.37, vol_fading=yes
Cup & Handle
bullish
early
60%
built
Cup base building — 73% of the 17%-deep cup recovered. Watch for the right side to reach ~436.24, then a handle.
Pivot Watch
4.52% away
Tightness / volume
Expanding · No VDU
Recent-pace band
3–8 sessions
Confirms above
436.24
Invalidates at
399.61
Rim
436.24
Cup Low
362.98
Pivot
436.24
Mid Cup
399.61
Cup depth 17%, recovery 73%, handle=not yet
Predictive pattern recognition is educational — most forming structures never confirm. Wait for the confirmation level before treating this as a setup.
Pattern Analysis
82
setup score
RS Score
64
Trend template
7/8
Why This Setup?
Trend Only · schematic
Gatekeeper 7/8 | Strong trend (7/8) | Good RS (64) | Volume surging | Accumulation (1.7× up/dn vol) | Stage 2 | Gap-up day (1.6× vol)
The Universal Edge Check · context only
What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.
3/7
universals met
- A relative-strength leader — not met RS rank 55 — laggard
- Risk is defined — not met No stop — undefined risk
- Asymmetric reward — partly met No target set
- Not chasing (in range) — partly met Pivot distance unknown
- Clear of earnings — met in 37 days
- In a confirmed uptrend — met Stage 2 · Trend template 7/8
- Volume confirms — met 1.6× average
Minervini Trend Template
7/8Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.
Price above SMA 150 & 200
$416.54 vs SMA150 $363.91 / SMA200 $360.57
SMA 150 above SMA 200
SMA150 $363.91 vs SMA200 $360.57
SMA 200 trending up
Slope +7.76 over 20 days
SMA 50 above SMA 150 & 200
SMA50 $397.20
Price above SMA 50
$416.54 vs SMA50 $397.20
30%+ above 52-week low
+51.6% from $274.84
Within 25% of 52-week high
-4.5% from $436.24
RS score above 70
RS 64
Fundamentals
52W Range
88%
Mkt Cap SEC
90.3B
Rev YoY
+12%
EPS TTM
$25.21
P/E TTM
16.5x
Float
217M
Company
Company profile
Elevance Health, Inc.
Weekly Context
Multi-timeframe signals from weekly barsW. Trend
8/8
W. RS
71
W. Support
$274.84
W. Resist
$436.24
Weekly Structure
Trend
Neutral
Tight Weeks
0
Confirmation
Neutral
Scan History
20× streakSep 11
Trend Only
✓ Gate
82
Sep 11
Trend Only
✓ Gate
80
Sep 11
Trend Only
✓ Gate
78
Sep 10
Trend Only
✓ Gate
69
0.0%
Sep 10
Trend Only
✓ Gate
67
0.0%
Sep 09
Trend Only
✓ Gate
77
+4.9%
Get the full picture on ELV
Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.
Start 7-Day Free Trial